What's new

Human medicines European public assessment report (EPAR): Rybrevant, amivantamab, Date of authorisation: 09/12/2021, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Rybrevant, amivantamab, Date of authorisation: 09/12/2021, Revision: 7, Status: Authorised

Jun 12, 2025 - 16:25
 0
Human medicines European public assessment report (EPAR): Rybrevant, amivantamab, Date of authorisation: 09/12/2021, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Rybrevant, amivantamab, Date of authorisation: 09/12/2021, Revision: 7, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Sugammadex Piramal, su...

Next Article

Navy will consolidate Medium, Large USV programs: GAO

Related Posts

Draft reflection paper on data recommendations for herb...

Jun 2, 2025  0

Human medicines European public assessment report (EPAR): Verzenios, abemaciclib, Date of authorisation: 26/09/2018, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 2, 2025  0

Human medicines European public assessment report (EPAR): Otulfi, ustekinumab, Date of authorisation: 25/09/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

May 26, 2025  0